Epiomic Epidemiology Series: Ulcerative Colitis Forecast in 8 Major Markets 2016-2026
Ulcerative Colitis (UC) is an inflammatory bowel disease (IBD) causing chronic inflammation in the colon, and is treated as an autoimmune disease. While sharing some features with Crohn's disease, UC is an intermittent disease with periods of symptoms interspersed with asymptomatic periods (generally induced by response to treatment). The disease involves the rectum up to the colon and is classified according to length of colon affected.
This report provides the current prevalent population for Ulcerative Colitis across 8 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Ulcerative Colitis have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main symptoms and co-morbidities for Ulcerative Colitis include:
• Anaemia
• Gastritis
• Colorectal cancer
• Osteoporosis
• Complications from surgery
• Pouchitis
• Toxic megacolon
• Extra-intestinal features (e.g. primary sclerosing cholangitis, erythema nodosum)
This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.
Reason to buy
• Able to quantify patient populations in global Ulcerative Colitis’s market to target the development of future products, pricing strategies and launch plans.
• Gain further insight into the prevalence of the subdivided types of Ulcerative Colitis and identify patient segments with high potential.
• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
• Provide a level of understanding on the impact from specific co-morbid conditions on Ulcerative Colitis’s prevalent population.
• Identify sub-populations within Ulcerative Colitis which require treatment.
• Gain an understanding of the specific markets that have the largest number of Ulcerative Colitis patients.
This report provides the current prevalent population for Ulcerative Colitis across 8 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Ulcerative Colitis have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main symptoms and co-morbidities for Ulcerative Colitis include:
• Anaemia
• Gastritis
• Colorectal cancer
• Osteoporosis
• Complications from surgery
• Pouchitis
• Toxic megacolon
• Extra-intestinal features (e.g. primary sclerosing cholangitis, erythema nodosum)
This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.
Reason to buy
• Able to quantify patient populations in global Ulcerative Colitis’s market to target the development of future products, pricing strategies and launch plans.
• Gain further insight into the prevalence of the subdivided types of Ulcerative Colitis and identify patient segments with high potential.
• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
• Provide a level of understanding on the impact from specific co-morbid conditions on Ulcerative Colitis’s prevalent population.
• Identify sub-populations within Ulcerative Colitis which require treatment.
• Gain an understanding of the specific markets that have the largest number of Ulcerative Colitis patients.
Introduction
Cause of the Disease
Risk Factors & Prevention
Diagnosis of the Disease
Variation by Geography/Ethnicity
Disease Prognosis &Clinical Course
Key Co-morbid Conditions /Features Associated with the Disease
Methodology for Quantification of Patient Numbers
Top-Line Prevalence for Ulcerative Colitis
Features of Ulcerative Colitis Patients
Severity and Type of Involvement in UC
Contributing Factors t UC Development
Associated Conditions of Ulcerative Colitis
Skeletal Associated Conditions
Dermatological Associated Conditions
Digestive System Related Conditions
Haematological & Protein Conditions
Abbreviations used in the Report
Other Black Swan Analysis Publications
Black Swan Analysis Online Patient-Based Databases
Patient-Based Offering
Online Pricing Data and Platforms
References
Appendix
Cause of the Disease
Risk Factors & Prevention
Diagnosis of the Disease
Variation by Geography/Ethnicity
Disease Prognosis &Clinical Course
Key Co-morbid Conditions /Features Associated with the Disease
Methodology for Quantification of Patient Numbers
Top-Line Prevalence for Ulcerative Colitis
Features of Ulcerative Colitis Patients
Severity and Type of Involvement in UC
Contributing Factors t UC Development
Associated Conditions of Ulcerative Colitis
Skeletal Associated Conditions
Dermatological Associated Conditions
Digestive System Related Conditions
Haematological & Protein Conditions
Abbreviations used in the Report
Other Black Swan Analysis Publications
Black Swan Analysis Online Patient-Based Databases
Patient-Based Offering
Online Pricing Data and Platforms
References
Appendix
LIST OF TABLES
Severity index for adult UC patients
Prevalence of Ulcerative Colitis, total (000s)
Prevalence of Ulcerative Colitis, males (000s)
Prevalence of Ulcerative Colitis, females (000s)
Extent of involvement at diagnosis in Ulcerative Colitis patients, total (000s)
Severity of Ulcerative Colitis at diagnosis in patients, total (000s)
Smoking status of Ulcerative Colitis patients, total (000s)
Ulcerative Colitis patients with family history of UC, total (000s)
Prevalence of osteoporosis in Ulcerative Colitis patients, total (000s)
Prevalence of peripheral arthritis in Ulcerative Colitis patients, total (000s)
Prevalence of ankylosing spondylitis in Ulcerative Colitis patients, total (000s)
Prevalence of oral ulcerations in Ulcerative Colitis patients, total (000s)
Prevalence of pyoderma gangrenosum in Ulcerative Colitis patients, total (000s)
Prevalence of primary sclerosing cholangitis in Ulcerative Colitis patients, total (000s)
Prevalence of gastritis in Ulcerative Colitis patients, total (000s)
Type of gastritis in Ulcerative Colitis patients, total (000s)
Prevalence of anaemia in Ulcerative Colitis patients, total (000s)
Prevalence of elevated CRP in Ulcerative Colitis patients, total (000s)
Prevalence of elevated ESR in Ulcerative Colitis patients, total (000s)
Abbreviations and Acronyms used in the report
USA Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
USA Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
France Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
France Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
Germany Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
Germany Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
Italy Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
Italy Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
Spain Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
Spain Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
United Kingdom Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
United Kingdom Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
Brazil Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
Brazil Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
Japan Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
Japan Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
Severity index for adult UC patients
Prevalence of Ulcerative Colitis, total (000s)
Prevalence of Ulcerative Colitis, males (000s)
Prevalence of Ulcerative Colitis, females (000s)
Extent of involvement at diagnosis in Ulcerative Colitis patients, total (000s)
Severity of Ulcerative Colitis at diagnosis in patients, total (000s)
Smoking status of Ulcerative Colitis patients, total (000s)
Ulcerative Colitis patients with family history of UC, total (000s)
Prevalence of osteoporosis in Ulcerative Colitis patients, total (000s)
Prevalence of peripheral arthritis in Ulcerative Colitis patients, total (000s)
Prevalence of ankylosing spondylitis in Ulcerative Colitis patients, total (000s)
Prevalence of oral ulcerations in Ulcerative Colitis patients, total (000s)
Prevalence of pyoderma gangrenosum in Ulcerative Colitis patients, total (000s)
Prevalence of primary sclerosing cholangitis in Ulcerative Colitis patients, total (000s)
Prevalence of gastritis in Ulcerative Colitis patients, total (000s)
Type of gastritis in Ulcerative Colitis patients, total (000s)
Prevalence of anaemia in Ulcerative Colitis patients, total (000s)
Prevalence of elevated CRP in Ulcerative Colitis patients, total (000s)
Prevalence of elevated ESR in Ulcerative Colitis patients, total (000s)
Abbreviations and Acronyms used in the report
USA Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
USA Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
France Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
France Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
Germany Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
Germany Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
Italy Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
Italy Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
Spain Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
Spain Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
United Kingdom Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
United Kingdom Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
Brazil Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
Brazil Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
Japan Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
Japan Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
